An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma
Splenic marginal zone lymphoma (SMZL) is an indolent B-cell lymphoproliferative disorder characterised by 7q32 deletion, but the target genes of this deletion remain unknown. In order to elucidate the genetic target of this deletion, we performed an integrative analysis of the genetic, epigenetic, t...
Saved in:
Published in | PloS one Vol. 7; no. 9; p. e44997 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
13.09.2012
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Splenic marginal zone lymphoma (SMZL) is an indolent B-cell lymphoproliferative disorder characterised by 7q32 deletion, but the target genes of this deletion remain unknown. In order to elucidate the genetic target of this deletion, we performed an integrative analysis of the genetic, epigenetic, transcriptomic and miRNomic data. High resolution array comparative genomic hybridization of 56 cases of SMZL delineated a minimally deleted region (2.8 Mb) at 7q32, but showed no evidence of any cryptic homozygous deletion or recurrent breakpoint in this region. Integrated transcriptomic analysis confirmed significant under-expression of a number of genes in this region in cases of SMZL with deletion, several of which showed hypermethylation. In addition, a cluster of 8 miRNA in this region showed under-expression in cases with the deletion, and three (miR-182/96/183) were also significantly under-expressed (P<0.05) in SMZL relative to other lymphomas. Genomic sequencing of these miRNA and IRF5, a strong candidate gene, did not show any evidence of somatic mutation in SMZL. These observations provide valuable guidance for further characterisation of 7q deletion. |
---|---|
Bibliography: | Conceived and designed the experiments: AJW MQD. Performed the experiments: AJW RAH NZ QY YH EB RF EDM AD. Analyzed the data: AJW RAH EB RF EDM AD MQD. Contributed reagents/materials/analysis tools: HL JZ LdL PGI AW EB RF EDM AD. Wrote the paper: AJW MQD. Competing Interests: All authors have declared that no competing interests exist. The Mayo Clinic is a nonprofit medical center and therefore should not be considered a commercial company. All the authors from Mayo Clinic have declared that no competing interests exist for this manuscript. These authors also contributed equally to this work. |
ISSN: | 1932-6203 1932-6203 |
DOI: | 10.1371/journal.pone.0044997 |